当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析 - 现金流量表

山东药玻

(600529)

  

流通市值:141.68亿  总市值:141.68亿
流通股本:6.64亿   总股本:6.64亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,615,291,303.221,299,504,847.715,078,540,538.753,872,882,678.24
  收到的税费返还27,151,453.1125,697,348.0543,746,574.9442,458,812.4
  收到其他与经营活动有关的现金12,593,334.843,498,454.3116,453,803.9683,775,519.92
  经营活动现金流入小计2,655,036,091.171,328,700,650.065,238,740,917.653,999,117,010.56
  购买商品、接受劳务支付的现金1,700,775,028.38926,264,939.932,819,908,154.942,294,824,731.09
  支付给职工以及为职工支付的现金417,648,227.44220,246,011.93773,073,598.81552,086,021.85
  支付的各项税费173,279,219.5258,168,267.86318,303,408.2237,079,540.17
  支付其他与经营活动有关的现金63,892,869.1833,488,220.77162,405,387.8102,048,945.71
  经营活动现金流出小计2,355,595,344.521,238,167,440.494,073,690,549.753,186,039,238.82
  经营活动产生的现金流量净额299,440,746.6590,533,209.571,165,050,367.9813,077,771.74
二、投资活动产生的现金流量:
  收回投资收到的现金4,370,000,0001,590,000,0006,452,000,0004,752,000,000
  取得投资收益收到的现金16,034,426.498,445,300.537,309,842.0928,741,684.56
  处置固定资产、无形资产和其他长期资产收回的现金净额1,658,760280626,909404,687.86
  投资活动现金流入小计4,387,693,186.491,598,445,580.56,489,936,751.094,781,146,372.42
  购建固定资产、无形资产和其他长期资产支付的现金233,845,660.91108,412,908.91647,785,101.03455,855,757.55
  投资支付的现金4,340,000,0001,480,000,0006,960,000,0005,240,000,000
  投资活动现金流出小计4,573,845,660.911,588,412,908.917,607,785,101.035,695,855,757.55
  投资活动产生的现金流量净额-186,152,474.4210,032,671.59-1,117,848,349.94-914,709,385.13
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金180,554,602.56-464,529,879.1265,445,645.2
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计180,554,602.56-464,529,879.1265,445,645.2
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-180,554,602.56--464,529,879.1-265,445,645.2
四、汇率变动对现金及现金等价物的影响7,833,614.043,842,789.2915,608,495.179,611,409.5
五、现金及现金等价物净增加额-59,432,716.29104,408,670.45-401,719,365.97-357,465,849.09
  加:期初现金及现金等价物余额885,181,361.71885,181,361.711,286,900,727.681,286,900,727.68
  期末现金及现金等价物余额825,748,645.42989,590,032.16885,181,361.71929,434,878.59
补充资料:
  净利润371,141,622-942,991,305.41-
  资产减值准备48,839,146.75-61,157,836.83-
  固定资产和投资性房地产折旧193,580,334.75-378,434,342.15-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧193,580,334.75-378,434,342.15-
  无形资产摊销3,367,732.88-6,717,088.07-
  处置固定资产、无形资产和其他长期资产的损失-417,482.36--329,546.95-
  固定资产报废损失3,305,455.91-1,660,102.29-
  公允价值变动损失-6,447,381.91--24,463,237.31-
  财务费用-7,833,614.04--15,608,495.17-
  投资损失-7,227,203.39--11,633,529.78-
  递延所得税-15,314,856.45--36,652,939.97-
  其中:递延所得税资产减少-15,314,856.45--36,652,939.97-
  存货的减少-311,626,265.06--280,139,889.92-
  经营性应收项目的减少159,305,280.05--141,176,717.87-
  经营性应付项目的增加-133,678,731.5-288,010,927.33-
  其他-2,013,132.91--5,200,513.93-
  现金的期末余额825,748,645.42-885,181,361.71-
  减:现金的期初余额885,181,361.71-1,286,900,727.68-
  现金及现金等价物的净增加额-59,432,716.29--401,719,365.97-
公告日期2025-08-262025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑